(NYSE: BLCO) Bausch & Lomb's forecast annual revenue growth rate of 5.42% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.51%.
Bausch & Lomb's revenue in 2026 is $5,324,000,000.On average, 15 Wall Street analysts forecast BLCO's revenue for 2026 to be $2,001,554,038,584, with the lowest BLCO revenue forecast at $1,916,191,544,790, and the highest BLCO revenue forecast at $2,064,057,956,634. On average, 15 Wall Street analysts forecast BLCO's revenue for 2027 to be $2,114,775,421,566, with the lowest BLCO revenue forecast at $2,006,911,517,274, and the highest BLCO revenue forecast at $2,194,066,106,178.
In 2028, BLCO is forecast to generate $2,227,639,639,302 in revenue, with the lowest revenue forecast at $2,093,345,506,806 and the highest revenue forecast at $2,316,216,620,310.